Article Information
PubMed
Print ISSN
Online ISSN
History
- Received December 15, 2010
- Accepted March 21, 2011
- Published online June 17, 2011.
Article Versions
- Earlier version (March 24, 2011 - 11:00).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Xiaofeng Li,
- Juergen Delzer,
- Richard Voorman,
- Sonia M. de Morais and
- Yanbin Lao
- Drug Metabolism, Pharmacokinetics and Bioanalysis, Abbott Laboratories, Abbott Park, Illinois (X.L., R.V., S.M.d.M., Y.L.); and Drug Metabolism, Pharmacokinetics and Bioanalysis, Abbott Laboratories, Ludwigshafen, Germany (J.D.)
- Address correspondence to:
Dr. Yanbin Lao, Drug Metabolism, Pharmacokinetics and Bioanalysis, Abbott Laboratories, Abbott Park, IL 60044. E-mail: yanbin.lao{at}abbott.com
Parts of this work were previously presented at the following conference: Voorman R, Li X, Shoemaker A, Penning T, Giranda V, Delzer J, de Morais S, and Lao Y (2010) Veliparib (ABT-888), a novel, potent PARP inhibitor with favorable ADME properties. Abstract P142. 9th International ISSX Meeting; 2010 Sept 4–8; Istanbul, Turkey. International Society for the Study of Xenobiotics, Washington, DC.
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement